Conversely, no increase in the IFN-α response has been observed in the non-obese volunteers, thus confirming the key role of SOCS3 in inhibiting IFN-I after TLR stimulation in obesity [78]. The gene discussed is IFNA2; the disease is obesity due to melanocortin 4 receptor deficiency.